News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Integra LifeSciences Corporation (IART) Introduces Next-Generation Licox® Brain Tissue Oxygen Monitoring System



10/21/2013 9:17:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PLAINSBORO, N.J., Oct. 21, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the next-generation Licox® Brain Tissue Oxygen Monitoring System. The Licox system continually monitors brain oxygen partial pressure (PtO2) in patients who have sustained a traumatic brain injury or cerebral vascular event. The Licox system provides clinicians with early warning of hypoxic events, allowing more timely intervention to restore oxygen delivery to the vital tissues of the brain. It is the most widely studied and documented direct cerebral tissue oxygen monitoring device available to the clinician, and has been widely used in neurocritical care since it was launched in the United States in 2001. The new Licox system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and will be featured at the Congress of Neurological Surgeons (CNS) annual meeting, October 19 - 23, 2013, in San Francisco, California.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES